Key Record Dates
ClinicalTrials.gov Identifier: | NCT04590326 |
---|---|
Brief Title: | Study of REGN5668 Administered in Combination With Cemiplimab or REGN4018 in Adult Women With Recurrent Ovarian Cancer. |
First Submitted : | October 9, 2020 |
First Submitted that Met QC Criteria : | October 9, 2020 |
First Posted : | October 19, 2020 |
Last Update Submitted that Met QC Criteria : | January 21, 2021 |
Last Update Posted : | January 22, 2021 |